Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Non Small Cell Lung Cancer × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 100 Carcinoma, Non-Small-Cell Lung 26 Neoplasms 23 Neoplasm Metastasis 16 Carcinoma, Renal Cell 16 Prostatic Neoplasms 15 Uveal Melanoma 14 Lung Neoplasms 12 Pancreatic Neoplasms 11 Diabetes Mellitus, Insulin-Dependent, 12 11 Small Cell Lung Carcinoma 10 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Stomach Neoplasms 6 Sarcoma 6 Mesothelioma 6 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Endometrial Neoplasms 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4

Interventions

Vinorelbine 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03351361 2023-03-01

eNERGY

Rennes University Hospital

Phase 3 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡